Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors: Systemic Impact Versus Local Objective Benefits and Quality of Life
Phase of Trial: Phase IV
Latest Information Update: 29 Mar 2017
At a glance
- Drugs Estradiol (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- 27 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Aug 2017.
- 27 Apr 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Aug 2017.
- 21 Aug 2015 New trial record